Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0632ATC

LL/2(LLc1) Mouse Lung Lung Cancer Specialized Cells

Tumor Cell Lines > Lung Cancer Cell Lines

Product Type: Mouse Lung Cancer Cell Lines

Species: Mouse

Cell Type: Other / Specialized Cells

Source Organ: Lung

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: LL/2(LLc1)

Mouse C57BL Lewis lung carcinoma. Derived from the lung of a C57BL mouse implanted with a primary Lewis Lung carcinoma. The cells can be used as a model for metastasis and for studying the effects of chemotherapeutic agents.

  • Description
    The Lewis lung carcinoma line 1 (LLC1), also known as LL/2, is a murine lung cancer cell line originally derived from a primary tumor in a C57BL/6 mouse. This syngeneic, immunocompetent model remains highly tumorigenic and metastatic, faithfully replicating the behavior of primary Lewis lung carcinoma, including lung colonization. LLC1 cells exhibit epithelial-like adherent morphology, grow efficiently in RPMI-1640 with 2% FCS or DMEM with 10% FBS. They are chromosomally abnormal and express both cytokeratin and vimentin, indicating epithelial-mesenchymal characteristics. These cells are tested negative for mycoplasma, bacteria, fungi, HIV, HBV, and HCV. LLC1 is widely used in metastasis, chemotherapy, and immunotherapy research, providing a reliable and reproducible murine model for preclinical lung cancer studies under physiologically relevant conditions.
  • Product Name
    LL/2(LLc1)
  • Product Type
    Mouse Lung Cancer Cell Lines
  • Species
    Mouse
  • Source Organ
    Lung
  • Disease
    Lung Cancer
  • Product Type
    Mouse Lung Cancer Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    LL-2(LLC1) cells have broad s in cancer research. They are useful in focus assays to assess drug-triggered cell death, providing insights into the impacts of different agents on cancer cell viability. Additionally, LL-2(LLC1) cells are commonly employed in syngeneic animal models to assess the efficacy of anticancer treatments in vivo. These models enable researchers to study treatment effectiveness and potential side effects in a controlled environment. Furthermore, LL-2(LLC1) cells are valuable in identifying key factors in human cancer. Researchers can test effects of antibodies or blockers on LL-2(LLC1) cells, shedding light on potential therapeutic targets and aiding in the development of targeted cancer therapies. Overall, LL-2(LLC1) cells serve as valuable tools for studying drug action, therapy results, and molecular targets in cancer biology.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    DMEM + 10% HS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you